A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2

PHASE3TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 2, 2022

Primary Completion Date

July 8, 2024

Study Completion Date

July 8, 2024

Conditions
Ventilator Associated PneumoniaStaphylococcus Aureus
Interventions
BIOLOGICAL

Suvratoxumab

Monoclonal antibody

DRUG

Placebo

Placebo contains only excipients

Trial Locations (27)

87042

Fra06, Limoges

Unknown

Research Site Bel03, Haine-Saint-Paul

Research Site Bel02, Ottignies

Research Site Bel05, Yvoir

Research Site Fra05, Argenteuil

Research Site Fra16, La Roche-sur-Yon

Research Site Fra10, Le Mans

Research Site Fra08, Lille

Research Site Fra07, Orléans

Research Site Fra15, Pierre-Bénite

Research Site Fra12, Tours

Research Site Fra03, Trévenans

Research Site GRC01, Larissa

Research Site ISR03, Haifa

Research Site ISR05, Holon

Research Site ISR01, Ramat Gan

Research Site ISR06, Safed

Research Site NLD01, Enschede

Research Site NLD03, Heerlen

Research Site NLD02, Utrecht

Research Site SPA04, Barcelona

Research Site SPA01, Córdoba

Research Site SPA07, Madrid

Research Site SPA08, Santander

Research Site SPA06, Santiago de Compostela

Research Site SPA03, Terrassa

Research Site SPA05, Valencia

Sponsors
All Listed Sponsors
lead

Aridis Pharmaceuticals, Inc.

INDUSTRY